Ellington Management Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-9,300
| Closed | -$786K | – | 73 |
|
|
2020
Q1 | $786K | Buy |
9,300
+5,600
| +151% | +$473K | 0.18% | 145 |
|
|
2019
Q4 | $313K | Buy |
+3,700
| New | +$313K | 0.07% | 273 |
|
|
2019
Q3 | – | Sell |
-6,100
| Closed | -$522K | – | 580 |
|
|
2019
Q2 | $522K | Buy |
+6,100
| New | +$522K | 0.09% | 208 |
|
|
2019
Q1 | – | Sell |
-2,600
| Closed | -$221K | – | 543 |
|
|
2018
Q4 | $221K | Buy |
+2,600
| New | +$221K | 0.07% | 269 |
|
|
2018
Q1 | – | Sell |
-8,400
| Closed | -$749K | – | 807 |
|
|
2017
Q4 | $749K | Buy |
+8,400
| New | +$749K | 0.12% | 125 |
|
|
2014
Q1 | – | Sell |
-4,000
| Closed | -$281K | – | 609 |
|
|
2013
Q4 | $281K | Buy |
+4,000
| New | +$281K | 0.1% | 337 |
|